Excelra’s Post

Now available on demand! Watch our recent #webinar discussing scientific innovations that are expanding the druggable space and enabling greater discovery of novel targets: https://bit.ly/3xKrkfz Presenters Dr. Mo Jain and Dr. Jonathan Usuka answer questions such as: ▶️ What therapeutic opportunities await #pharma developers now with innovative new drug modalities that can engage previously difficult-to-drug proteins? ▶️ How are technological advances in mass spectrometry changing the landscape of discovery #proteomics for target ID? ▶️ How is AI-based #multiomics data integration able to help prioritize the best targets to pursue? Download the full recording to hear these answers and more! https://bit.ly/3xKrkfz #targetidentification #targetvalidation #proteintargets

AI for Good: ALS drug discovery The Details: ALS, known also as Lou Gehrig’s disease, doesn’t currently have a cure.  Because of this, it has become an area of focus for some biotech and pharmaceutical companies.  Why it matters: “For years, researchers have heavily relied on animal or cell models to identify new targets, in a way that oversimplifies the enormous complexity of human biology, particularly for diseases like ALS,” Dr. Robert H. Scannevin, Verge’s chief scientific officer, said in a statement. “The Converge platform starts with, and integrates, human data and human model systems throughout discovery and development,” providing “unique insights into the biological underpinnings of ALS.” #clinicalresearch #ALS

Do the following question keep you awake all day.. 😁 ▶️ What therapeutic opportunities await #pharma developers now with innovative new drug modalities that can engage previously difficult-to-drug proteins? ▶️ How are technological advances in mass spectrometry changing the landscape of discovery hashtag #proteomics for target ID? ▶️ How is AI-based hashtag #multiomics data integration able to help prioritize the best targets to pursue? Why not tune into our latest WEBINAR and uncover some answers before your summer break

Don't miss Janet Piñero, our Head of Bioinformatics, presenting at BioTechX! You may already be familiar with DISGENET, but have you seen the brand new platform? DISGENET simplifies gene-disease research by integrating scattered data from diverse data sources, such as databases scientific literature, and clinical trials, into a single resource. Join Janet on Wednesday, October 9th at 5:05 PM in Theatre 3 to learn about DISGENET's new features and its potential to accelerate drug discovery and precision medicine. Visit us at booth 620 or send a meeting request. We'd love to connect with you during the conference! #BioTechX #Pharma #Biotech #Bioinformatics #Genomics #PrecisionMedicine #DISGENET #DataForTomorrowsHealth

Missed SLAS earlier this month? Make sure to download our poster! From the 3rd to 7th February, we were in Boston for the Society for Laboratory Automation and Screening (SLAS) International Conference, discussing our work with human iPSC technology for research and drug discovery. Alongside discussions on quality iPSC manufacturing, functional QC and in vitro models, we presented a poster titled "Differentiation of multiple iPSC lines to different cell types to enable cohort analysis in neurodegeneration: challenges and learnings". Listen to our Project Manager, Sian Humphreys presenting the key findings in the poster: https://hubs.la/Q02m2bc70 Click here to download the poster: https://hubs.la/Q02m24Zy0 #iPSCs #SLAS #biotech #StemCells #DrugDiscovery

Now available on demand! Watch our recent #webinar discussing scientific innovations that are expanding the druggable space and enabling greater discovery of novel targets: https://lnkd.in/eNgUxKaM Presenters Mo Jain, MD PhD and Jonathan Usuka answer questions such as: ▶️ What therapeutic opportunities await #pharma developers now with innovative new drug modalities that can engage previously difficult-to-drug proteins? ▶️ How are technological advances in mass spectrometry changing the landscape of discovery #proteomics for target ID? ▶️ How is AI-based #multiomics data integration able to help prioritize the best targets to pursue? Download the full recording to hear these answers and more! https://lnkd.in/eNgUxKaM Oxford Global #targetidentification #targetvalidation #proteintargets

Unleashing the Power of Genomics: Market Set to Revolutionize Healthcare Download PDF Brochure:-https://lnkd.in/d-c84eV2 The global genomics market in terms of revenue was estimated to be worth $46.2 billion in 2023 and is poised to reach $83.1 billion by 2028, growing at a CAGR of 12.4% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Illumina, Thermo Fisher Scientific, Danaher Corporation QIAGEN Agilent Technologies, PerkinElmer Wohlfahrtsstiftung der F. Hoffmann-La Roche AG Bio-Rad Laboratories, Eurofins Scientific Finland Oy PACIFIC BIOSCIENCES OF CALIF Oxford Nanopore Technologies Abbott Takara Bio Inc. BGI Group Eppendorf Merck KGaA, Darmstadt, Germany New England Biolabs Promega Corporation Creative Biogene Novogene., 23andMe, 10x Genomics Ultima Genomics, Freenome Holdings Inc, Helix Polaris Genomics Personalis, Inc. Myriad Genetics, Quest Diagnostics Phalanx Biotech Group genomiQa Pty Ltd. #genomics #genomicresearch #nextgensequencing #precisionmedicine #genomicdata

Genomics Market worth $83.1 billion by 2028 Download PDF Brochure: https://lnkd.in/d8Efxmdd The global genomics market in terms of revenue was estimated to be worth $46.2 billion in 2023 and is poised to reach $83.1 billion by 2028, growing at a CAGR of 12.4% from 2023 to 2028. Top key Players : Illumina, Thermo Fisher Scientific, Danaher Corporation QIAGEN Agilent Technologies, PerkinElmer Wohlfahrtsstiftung der F. Hoffmann-La Roche AG Bio-Rad Laboratories, Eurofins Scientific AG (Switzerland) PACIFIC BIOSCIENCES OF CALIF Oxford Nanopore Technologies Abbott Takara Bio USA, Inc. BGI Group Eppendorf Merck New England Biolabs Promega Corporation Creative Biogene Novogene., 23andMe, 10x Genomics Ultima Genomics, Freenome Holdings Inc, Helix Polaris Genomics Personalis, Inc. Myriad Genetics, Quest Diagnostics Phalanx Biotech Group genomiQa Pty Ltd. #genomics #geneticresearch #personalizedmedicine #biotech #genomesequencing

🌍 Exciting News! iBio, Inc.'s Chief Financial Officer, Felipe D., will be attending #BioEurope2024 in Stockholm, Sweden, next month! 🌍 This key event brings together top biotech and pharma leaders and over 5,000 industry professionals. Felipe will discuss iBio’s innovative AI-driven platform and explore potential partnerships for our growing pipeline in immuno-oncology and cardiometabolic diseases. At iBio, we're leveraging machine learning and epitope engineering to accelerate drug discovery and development—making major strides in tackling some of the most challenging targets. 💡 Interested in connecting with Felipe? Drop a message or schedule a meeting at the event! Let’s explore how we can collaborate. #BioEurope #Biotech #AI #ImmunoOncology #Cardiometabolic #MachineLearning #Partnerships #DrugDiscovery #Pharma #iBio